Case File
efta-02018266DOJ Data Set 10OtherEFTA02018266
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02018266
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
.eevacation
[email protected]: .11jeevacationgogmall.com1
From:
Sent
un 1 /21/2012 3:31:09 PM
Subject: Re:
Aaah thank you
Sent from my iPhone
On Oct 21, 2012, at 11:20 AM, J [email protected]> wrote:
Wrap in bread
Sent from my iPad
On Oct 21, 2012, at 10:59 AMS
wrote:
Thank you, I have also researched. I am on the 60. I will try cutting
one in half so that it will equal 90. It is a capsule with powder in that
bums but I will try.
Sent from my iPhone
On Oct 21, 2012, at 7:14 AM, Jeffrey Epstein <[email protected]> wrote:
you are on the lowest recomment dose not the highest.
if you are taking 30„ s take one additional this week to
start if not try cutting a 60 in half and add
Generalized Anxiety Disorder — It is generally agreed
that episodes of generalized anxiety disorder require
several months or longer of sustained pharmacological
therapy. Maintenance of efficacy in GAD was
demonstrated with Cymbalta as monotherapy. Cymbalta
should be administered in a dose range of 60-120 mg
once daily. Patients should be periodically reassessed to
determine the continued need for maintenance treatment
and the appropriate dose for such treatment [see Clinical
Studies ( JA,2)].
***********************************************************
The information contained in this communication is
EFTA_R1_00522148
EFTA02018266
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00522149
EFTA02018267
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.